Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Diagn Interv Imaging ; 99(7-8): 493-499, 2018.
Article in English | MEDLINE | ID: mdl-29501461

ABSTRACT

PURPOSE: To assess the usefulness of a second biopsy when the first one was inconclusive in patients with a liver nodule found during the follow-up for chronic liver disease. MATERIALS AND METHODS: Among 381 patients (544 nodules) included in a prospective study designed to evaluate the accuracy of imaging for the diagnosis of small hepatocellular carcinoma (HCC) in chronic liver disease, 254 nodules were biopsied. The following histological results were considered as conclusive: HCC, dysplastic or regenerative nodule, and other identified tumors (benign or malignant). For nodules with inconclusive results (e.g. fibrosis or no definite focal lesion), a second biopsy was suggested, but was not mandatory. RESULTS: A total of 242 patients (194 men, 48 women; mean age, 61.9±9.5 [SD]; range: 40.2-89.0years) with 254 nodules underwent a first biopsy. Mean nodule diameter was 19.2±5.4mm (range: 10-33mm). The first biopsy was conclusive in 189/254 nodules (74.4%): 157 HCCs (83.1%), 11 regenerative nodules (5.8%), 10 dysplastic nodules (5.3%), 3 cholangiocarcinomas (1.6%), and 8 other tumors (4.2%). Among the 65 nodules for which the first biopsy was inconclusive, a second biopsy was performed for 17 nodules in 16 patients within 6 months of the first one. It was conclusive in 13/17 nodules (76.5%): 10 HCCs (76.9%), 2 dysplastic nodules (15.4%), and 1 other tumor (7.7%). In 4/17 nodules (23.5%), no definitive diagnosis could be provided. CONCLUSION: The diagnostic yield of a second biopsy of a suspicious lesion suggestive of HCC in chronic liver disease is not decreased compared to the first one. Repeated biopsy after a first negative one could be an alternative option to the follow-up of patients with chronic liver disease.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Diseases/pathology , Liver Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma, Hepatocellular/complications , Chronic Disease , Female , Humans , Liver Diseases/complications , Liver Neoplasms/complications , Male , Middle Aged , Prospective Studies
3.
Gait Posture ; 29(4): 587-91, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19168358

ABSTRACT

The objective of the study was to compare the precision of shoulder anatomical landmark palpation using a CAST-like method and a newly developed anatomical palpator device (called A-Palp) using the forefinger pulp directly. The repeated-measures experimental design included four examiners that twice repeated measurements on eleven scapula and humerus anatomical landmarks during two sessions. Inter-session and inter-examiner precision was determined on volunteers. A-Palp accuracy was obtained from in vitro measurements and using virtual palpation on 3D bone models. Error propagation on the motion representation was also analyzed for a continuous motion of abduction movement performed in the shoulder joint. Palpation results showed that CAST and A-Palp methods lead to similar precision with the Maximal A-Palp calibration error being 1.5mm. In vivo precision of the CAST and A-Palp methods varied between 4mm (inter-session) and 8mm (inter-examiner). Mean propagation of the palpation error on the motion graph representation was 2 degrees and 5 degrees for scapula and humerus, respectively. A-Palp accuracy was 3.6 and 8.1mm for scapula and humerus, respectively. The A-Palp seems promising and could probably become an additional method next to today's marker-based motion analysis systems (i.e., Helen-Hayes configuration, CAST method).


Subject(s)
Palpation/methods , Shoulder Joint/anatomy & histology , Biomechanical Phenomena , Calibration , Humans , Models, Anatomic , Reproducibility of Results , Shoulder Joint/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...